GSK-961081; GSK-961081D; TD-5959; 961081; Batefenterol Succinate

GSK-961081; GSK-961081D; TD-5959; 961081; Batefenterol Succinate (R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl -2-ylcarbamate Other names:GSK-961081; GSK-961081D; TD-5959; 961081; Batefenterol Succinate Cas No:743461-65-6(Batefenterol) 945905-37-3(Batefenterol succinate)  Molecular formula:C40H42ClN5O7  Molecular weight:74024  Purity:98% 

(R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

(R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic acid (R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic aci Other names:(R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic acid Cas No:1516887-35-6  Molecular formula:C26H44O4  Molecular weight:42063  Purity:98% 

(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic acid (R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic acid Other names:(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic acid Cas No:915038-26-5  Molecular formula:C26H42O4  Molecular weight:41861  Purity:98% 

(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic acid (R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic acid Other names:(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopentaphenanthren-17-yl)pentanoic acid Cas No:NA  Molecular formula:C26H42O4  Molecular weight:41861  Purity:98%  SB431542

1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one

1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzoimidazol-2(3H)-one 1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzoimidazol-2(3H)-one Other names:1-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzoimidazol-2(3H)-one Cas No:NA  Molecular formula:C20H21F3N4O  Molecular weight:39040  Purity:98%  ITI-007